Immunovant logo

Immunovant Share Price Today

(NASDAQ: IMVT)

Immunovant share price is $22.07 & ₹1,911.10 as on 31 Jan 2025, 2.30 'hrs' IST

$22.07

0.28

(1.28%)

Market is closed - opens 8 PM, 31 Jan 2025

View live Immunovant share price in Dollar and Rupees. Guide to invest in Immunovant stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Immunovant, along with analyst recommendations, forecasts, and comprehensive financials.

Immunovant share price movements

  • Today's Low: $21.55
    Today's High: $22.15

    Day's Volatility :2.71%

  • 52 Weeks Low: $21.48
    52 Weeks High: $39.55

    52 Weeks Volatility :45.7%

Immunovant (IMVT) Returns

PeriodImmunovant IncSector (Health Care)Index (Russel 2000)
3 Months
-24.91%
0.3%
0.0%
6 Months
-20.81%
-1.5%
0.0%
1 Year
-38.81%
5.0%
0.0%
3 Years
215.74%
12.3%
-12.8%

Immunovant (IMVT) Key Statistics

in dollars & INR

Previous Close
$21.79
Open
$21.68
Today's High
$22.15
Today's Low
$21.55
Market Capitalization
$3.7B
Today's Volume
$1.7M
52 Week High
$39.55
52 Week Low
$21.475
Revenue TTM
$0.0
EBITDA
$-352.2M
Earnings Per Share (EPS)
$-2.21
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-92.17%

How to invest in Immunovant Stock (IMVT) from India?

It is very easy for Indian residents to invest directly in Immunovant from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Immunovant stock in both Indian Rupees (INR) and US Dollars (USD). Search for Immunovant or IMVT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Immunovant or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Immunovant shares which would translate to 0.039 fractional shares of Immunovant as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Immunovant, in just a few clicks!

Returns in Immunovant (IMVT) for Indian investors in Rupees

The Immunovant stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immunovant investment value today

Current value as on today

₹65,548

Returns

₹34,452

(-34.45%)

Returns from Immunovant Stock

₹38,813 (-38.81%)

Dollar Returns

₹4,362 (+4.36%)

Indian investors sentiment towards Immunovant (IMVT)

300%

Period: Dec 31, 2025 to Jan 30, 2025. Change in 30 Days versus previous period

Search interest for Immunovant Stock from India on INDmoney has increased by 300% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Immunovant

  • FMR Inc

    8.54%

  • Vanguard Group Inc

    4.54%

  • BlackRock Inc

    3.44%

  • Deep Track Capital, LP

    2.96%

  • Armistice Capital, LLC

    2.42%

  • T. Rowe Price Investment Management,Inc.

    2.27%

Analyst Recommendation on Immunovant

Buy

    95%Buy

    4%Hold

    0%Sell

Based on 22 Wall street analysts offering stock ratings for Immunovant(by analysts ranked 0 to 5 stars)

Based on 22 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
21
23
19
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Immunovant Stock (IMVT)

What analysts predicted

Upside of 127.31%

Target:

$50.17

Current:

$22.07

Insights on Immunovant Stock (Ticker Symbol: IMVT)

  • Price Movement

    In the last 3 years, IMVT stock has moved up by 215.7%
  • IMVT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 60.3% return, outperforming this stock by 99.7%

Immunovant Technicals Summary

Sell

Neutral

Buy

Immunovant is currently in a neutral trading position according to technical analysis indicators.

Immunovant (IMVT) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Immunovant Inc logo
-12.39%
-20.81%
-38.81%
215.74%
38.2%
Biontech Se logo
4.84%
47.4%
27.9%
-32.69%
299.34%
Regeneron Pharmaceuticals, Inc. logo
-4.49%
-36.88%
-28.68%
11.37%
100.25%
Vertex Pharmaceuticals Incorporated logo
8.04%
-11.34%
1.04%
78.46%
90.19%
Alnylam Pharmaceuticals, Inc. logo
18.64%
1.88%
58.45%
91.24%
141.72%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Immunovant Inc logo
NA
NA
NA
-2.89
-0.92
-0.55
NA
3.06
Biontech Se logo
160.8
NA
0.04
-3.32
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
17.01
17.01
1.06
45.08
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.16
0.49
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Immunovant Inc logo
Buy
$3.7B
38.2%
NA
0.0%
Biontech Se logo
Buy
$29.0B
299.34%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$75.5B
100.25%
17.01
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$113.7B
90.19%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.3B
141.72%
NA
-15.86%

Immunovant Dividend announcements

  • Immunovant Earnings

    Immunovant’s price-to-earnings ratio stands at None

    Read More

About Immunovant

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. The company develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, Graves diseases, and warm autoimmune hemolytic anemia. Immunovant, Inc. is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
Organization
Immunovant
Employees
207
CEO
Dr. Frank M. Torti M.B.A., M.D.
Industry
Finance

Management People of Immunovant

NameTitle
Dr. Frank M. Torti M.B.A., M.D.
Executive Chairperson of the Board
Dr. Peter Salzmann M.B.A., M.D.
CEO & Director
Dr. Jay S. Stout Ph.D.
Chief Technology Officer
Ms. Eva Renee Barnett M.B.A.
Chief Financial Officer
Ms. Melanie Gloria B.S.N.
Chief Operating Officer
Mr. Christopher A. Van Tuyl Esq., J.D.
Chief Legal Officer & Corporate Secretary
Ms. Lauren Schrier M.B.A.
Vice President of Marketing
Ms. Christine Blodgett
Senior Vice President of Human Resources
Dr. William L. Macias M.D., Ph.D.
Chief Medical Officer
Mr. Andy Deig
Senior Vice President of Strategic Finance

Important FAQs about investing in IMVT Stock from India :

What is Immunovant share price today?

Immunovant share price today stands at $22.07, Open: $21.68 ; Previous Close: $21.79 ; High: $22.15 ; Low: $21.55 ; 52 Week High: $39.55 ; 52 Week Low: $21.48.

The stock opens at $21.68, after a previous close of $21.79. The stock reached a daily high of $22.15 and a low of $21.55, with a 52-week high of $39.55 and a 52-week low of $21.48.

Can Indians buy Immunovant shares?

Yes, Indians can invest in the Immunovant (IMVT) from India.

With INDmoney, you can buy Immunovant at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Immunovant at zero transaction cost.

How can I buy Immunovant shares from India?

It is very easy to buy Immunovant from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Immunovant (IMVT) be purchased?

Yes, you can buy fractional shares of Immunovant with INDmoney app.

What are the documents required to start investing in Immunovant stocks?

To start investing in Immunovant, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Immunovant Stock (IMVT)?

Today’s highest price of Immunovant (IMVT) is $22.15.

Today’s lowest price of Immunovant (IMVT) is $21.55.

What is today's market capitalisation of Immunovant?

Today's market capitalisation of Immunovant IMVT is 3.7B

What is the 52 Week High and Low Range of Immunovant Stock (IMVT)?

  • 52 Week High

    $39.55

  • 52 Week Low

    $21.48

What are the historical returns of Immunovant (IMVT)?

  • 1 Month Returns

    -12.39%

  • 3 Months Returns

    -20.81%

  • 1 Year Returns

    -38.81%

  • 5 Years Returns

    38.2%

Who is the Chief Executive Officer (CEO) of Immunovant ?

Dr. Frank M. Torti M.B.A., M.D. is the current Chief Executive Officer (CEO) of Immunovant.